Rational design of novel, potent piperazinone and imidazolidinone BACE1 inhibitors
Cumming, J.N., Le, T.X., Babu, S., Carroll, C., Chen, X., Favreau, L., Gaspari, P., Guo, T., Hobbs, D.W., Huang, Y., Iserloh, U., Kennedy, M.E., Kuvelkar, R., Li, G., Lowrie, J., McHugh, N.A., Ozgur, L., Pan, J., Parker, E.M., Saionz, K., Stamford, A.W., Strickland, C., Tadesse, D., Voigt, J., Wang, L., Wu, Y., Zhang, L., Zhang, Q.(2008) Bioorg Med Chem Lett 18: 3236-3241
- PubMed: 18468890 
- DOI: https://doi.org/10.1016/j.bmcl.2008.04.050
- Primary Citation of Related Structures:  
3CIB, 3CIC, 3CID - PubMed Abstract: 
Guided by structure-based design, we synthesized two novel series of potent inhibitors of BACE1 and generated extensive SAR around both the prime and non-prime side binding pockets. The key feature of both series is a cyclic amine motif specifically crafted to achieve interactions with both the flap and with the S2' pocket.
Organizational Affiliation: 
Schering-Plough Research Institute, 2015 Galloping Hill Road, Kenilworth, NJ 07033, USA. jared.cumming@spcorp.com